Inicio>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Sphingomyelins (from bovine spinal cord)

Sphingomyelins (from bovine spinal cord) (Synonyms: SMs (porcine RBC))

Catalog No.GC44928

Las esfingomielinas (de la médula espinal bovina) son un esfingolÍpido eucariota y uno de los principales constituyentes de las membranas celulares y particularmente abundantes en la vaina de mielina que rodea los axones neuronales.

Products are for research use only. Not for human use. We do not sell to patients.

Sphingomyelins (from bovine spinal cord) Chemical Structure

Cas No.: 85187-10-6

Tamaño Precio Disponibilidad Cantidad
1mg
20,00 $
Disponible
5mg
74,00 $
Disponible
10mg
117,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sphingomyelins (SMs) are bioactive sphingolipids found in mammalian cell membranes. SMs make up 2-15% of the total organ phospholipid population but are found at higher concentrations in the brain and myelin sheaths surrounding peripheral nerves. They interact with cholesterol to control its distribution within cellular membranes and maintain cholesterol homeostasis in cells. SMs undergo hydrolysis by sphingomyelinase to form ceramides, which are sphingolipid mediators of intracellular signaling. This product is a mixture of SMs, with variable fatty acid chain lengths, extracted from bovine spinal cord.

Reseñas

Review for Sphingomyelins (from bovine spinal cord)

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sphingomyelins (from bovine spinal cord)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.